RNA therapeutics - delivering beyond the liver
Barcode Nanotech is developing selective delivery vehicles for RNA/DNA-based drugs. Our solution is a platform based on nanoparticles with precise target-site activity and release.
The company is developing unique nanoparticles for selective indications such as hard-to-treat-cancers and metabolic diseases and demonstrated an ability to target specific tissues and tumors.
Providing selective and enhanced RNA therapeutic delivery solutions
We have identified unique RNA-delivery nanoparticles for selective cell and tissue targets, through a proprietary in vivo & AI-based screening platform. Nanoparticles are formulated with proprietary lipids which enable effective encapsulation of various RNA or DNA-sequences as therapeutics or vaccines.